Mts1 Antibodies

Santa Cruz Biotechnology features a diverse variety of Mts1 Antibodies for investigating Mts1 protein function. Mts1 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Mts1, also known as S100A4, belongs to the S100 protein family and plays a crucial role in cellular processes such as cell motility, invasion, and metastasis. Research has shown that Mts1 expression significantly influences cancer progression through its involvement in various signaling pathways. Understanding Mts1 function continues to be a key focus in cancer research, as it may reveal new therapeutic opportunities. Scientists worldwide rely on high-quality monoclonal antibodies to advance their understanding of Mts1's biological significance. Current studies are exploring how Mts1 influences tumor development and metastatic processes. Ongoing research aims to uncover novel therapeutic strategies targeting Mts1-mediated pathways. Santa Cruz Biotechnology monoclonal antibodies enable researchers to conduct precise investigations that contribute to advancing cancer research and potential treatment options.